BACKGROUND Previous data suggest that reticulated platelets significantly affect antiplatelet response to thienopyridines. It is unknown whether parameters describing reticulated platelets can predict antiplatelet response to thienopyridines.
A ntiplatelet response to adenosine diphosphate (ADP)-receptor inhibitors, clopidogrel in particular, is associated with significant interindividual variability (1) (2) (3) . Multiple studies have demonstrated that patients with high on-clopidogrel platelet reactivity are at risk for major ischemic events such as myocardial infarction, stent thrombosis, or death (4-7). Several factors have been associated with this variability, including demographic and clinical variables, as well as genetic polymorphisms (8) (9) (10) (11) . However, all these factors predict only a minor proportion of the observed variability in response to clopidogrel and are therefore no substitute for platelet function testing (8, 10, 12, 13) .
Recently, several studies have shown that immature or "reticulated" platelets may be a novel predictor of impaired response to P2Y 12 receptor inhibitors (14) (15) (16) (17) . Further studies demonstrated an association between levels of reticulated platelets and adverse cardiovascular events in patients on P2Y 12 receptor inhibitors (18) (19) (20) . This platelet subpopulation presumably reflects platelet turnover and has initially been defined by a specific staining pattern of ribonucleic acids in light microscopy (21, 22) .
Given the improvement of laboratory techniques, reticulated platelet parameters are widely available for routine clinical use. Contemporary, fully automated cell analyzers providing blood count parameters can also determine reticulated platelets (23) . These analyzers provide multiple parameters describing reticulated platelets such as the absolute count (immature platelet count [IPC]), the fraction of the total platelet pool (immature platelet fraction [IPF]), and the fraction of highly reticulated platelets (highly fluorescent immature platelet fraction [hIPF] ). Previous studies have used different parameters to assess the impact of reticulated platelets on response to antiplatelet drugs (24) . We studied whether any of these parameters can independently predict on-treatment platelet reactivity compared with established predictors in patients treated with P2Y 12 receptor antagonists. days before enrollment; contraindication for aspirin or any of the study medications; oral anticoagulation; or any severe disorder of the coagulation system. Following coronary intervention, all patients were treated with a daily maintenance dose of aspirin 100 mg and clopidogrel 75 mg for at least 30 days as recommended by current guidelines (26, 27) .
METHODS

This
All patients gave written informed consent before angiography or any study procedure.
The study was approved by the ethics committee of the University of Freiburg (Germany) and the regulatory agency (Federal Institute for Drugs and Medical Devices, Bonn, Germany). The trial has been registered at the German Clinical Trial Register (DRKS00006102).
One of the key results of the ExcelsiorLOAD trial was that from 30 min onward, prasugrel 60 mg was associated with significantly stronger platelet inhibition than the clopidogrel 600-mg loading dose; indeed, prasugrel 60 mg roughly halved the time to onset of platelet inhibition compared with loading with clopidogrel 600 mg.
PLATELET FUNCTION TESTING AND ANALYSIS. Blood samples for platelet function testing were taken after randomization, immediately before intake of study medication and start of coronary intervention, and on day 1 following the procedure just before intake of the first maintenance dose of clopidogrel 75 mg. Blood was collected into 2.7-ml tubes containing r-hirudin (45 mg/ml, Sarstedt AG & Co., Nuembrecht, Germany). ADP (6.4 mmol/l)-induced platelet aggregation was assessed in whole blood by impedance aggregometry according to the manufacturer's instructions (Multiplate Analyzer, Roche Diagnostics, Mannheim, Germany). The area under the curve of aggregation units (AU) was recorded over 6 min, and results were described as AU Â min. High on-treatment platelet reactivity for the ADP test was defined as $468 AU Â min according to previously published data and consensus recommendations (28) . Immature Platelet Parameters and Thienopyridine Loading J U L Y 1 9 , 2 0 1 6 : 2 8 6 -9 3
RESULTS
Baseline characteristics of the 300 randomized patients were well balanced between cohorts of different loading regimens as previously published (25) . One patient in the prasugrel 60 mg group was In unadjusted linear regression analyses of the entire cohort, IPC and IPF were significantly associated with on-treatment platelet reactivity (IPC partial h 2 ¼ 0.07; p < 0.001; and IPF partial h 2 ¼ 0.02; p ¼ 0.02) ( Figure 2) . As for hIPF, it showed a strong trend but missed the level of significance Figure 1 . Prior studies focusing on reticulated platelets used thiazol orange staining as the detection method because fully automated assays were not available at that time. This staining method is prone to considerable interference, a major limitation for interpretation of these early findings (24) . More recent studies, including our analysis, applied wellstandardized analytical methods. However, most of these studies used IPF but did not include additional immature platelet parameters. In 2012, it was shown for the first time that IPF is associated with impaired response to clopidogrel in healthy volunteers (17) . 
